CARMAT SAS Announces the Assembly of the First Clinical Version of Its Artificial Heart

PARIS--(BUSINESS WIRE)--Regulatory News: •Achievement of a key milestone announced at the time of the company’s successful IPO on NYSE Alternext in July 2010 •These devices will be used for the first-in-man clinical trials scheduled for 2011